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Summary  17 
In recent years Venezuela has faced a severe economic crisis precipitated by political instability 18 
and declining oil revenue. Public health provision has suffered particularly. Herein, we assess the 19 
impact of Venezuela’s healthcare crisis on vector-borne diseases and the spillover to 20 
neighbouring countries. Between 2000-2015 Venezuela witnessed a 365% increase malaria cases 21 
followed by a 68% increase (319,765 cases) in late 2017. Neighbouring countries such as Brazil 22 
have reported an escalating trend of imported cases from Venezuela from 1,538 (2014) to 3,129 23 
(2017). Active Chagas disease transmission is reported with seroprevalence in children (<10 24 
years) as high as 12.5% in one community tested (N=64). There has been a nine-fold rise in the 25 
mean incidence of dengue between 1990 to 2016. Estimated rates of chikungunya and Zika are 26 
6,975 and 2,057 cases per 100,000 population, respectively, during their epidemic peaks. The re-27 
emergence of many vector-borne diseases represents a public health crisis in Venezuela and has 28 
the possibility of severely undermining regional disease elimination efforts. National, regional 29 
and global authorities must take action to address these worsening epidemics and prevent their 30 
expansion beyond Venezuelan borders. 31 
 32 
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Structured Summary 56 
Background: 57 
In recent years Venezuela has faced a severe economic crisis precipitated by political instability 58 
and a significant reduction in oil revenue. Public health provision has suffered particularly. 59 
Long-term shortages of medicines and medical supplies and an exodus of trained personnel have 60 
occurred against the backdrop of a surge in vector-borne parasitic and arboviral infections. 61 
Herein, we aim to assess comprehensively the impact of Venezuela’s healthcare crisis on vector-62 
borne diseases and the spillover to neighbouring countries. 63 
 64 
Methods 65 
Alongside the on-going challenges affecting the healthcare system, health-indicator statistics 66 
have become increasingly scarce. Official data from the Ministry of Health, for example, are no 67 
longer available. To provide and update on vector-borne disease in Venezuela, this study used 68 
individualized data from nongovernmental organizations, academic institutions and professional 69 
colleges, various local health authorities and epidemiological surveillance programs from 70 
neighbouring countries, as well as data available through international agencies.  71 
 72 
Findings 73 
Between 2000-2015 Venezuela witnessed a 365% increase malaria cases followed by a 68% 74 
increase (319,765 cases) in late 2017. Neighbouring countries such as Brazil have reported an 75 
escalating trend of imported cases from Venezuelan from 1,538 (2014) to 3,129 (2017). Active 76 
Chagas disease transmission is reported with seroprevalence in children (<10 years) as high as 77 
12.5% in one community tested (N=64). There has been a nine-fold rise in the mean incidence of 78 
dengue between 1990 to 2016. Estimated rates of chikungunya and Zika are 6,975 and 2,057 79 
cases per 100,000 population, respectively, during their epidemic peaks. 80 
 81 
Interpretation 82 
The re-emergence of many arthropod-borne endemic diseases has set in place an epidemic of 83 
unprecedented proportions, not only in Venezuela but in the region. Data presented here 84 
demonstrates the complex determinants of this situation. National, regional and global authorities 85 
must take action to address these worsening epidemics and prevent their expansion beyond 86 
Venezuelan borders. 87 
 88 
 89 
 90 
 91 
 92 
 93 
 94 
 95 
 96 
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Search strategy and selection criteria 97 
Malaria. Venezuela and Latin America data were sourced from PAHO Malaria Surveillance 98 
Indicators [Available from: http://ais.paho.org/phip/viz/malaria_surv_indicators_popup.asp] 99 
[cited 2018 May 05] and Observatorio Venezolano de la Salud / Documentos Oficiales 100 
[Available from: https://www.ovsalud.org/publicaciones/documentos-oficiales/] [cited 2018 May 101 
05]. Data from Brazilian border state data were accessed via the Brazilian Ministry if Health, 102 
Sistema de Vigilância. Epidemiológica – Malária [Available from: 103 
http://200.214.130.44/sivep_malaria/] [cited 2018 May 05]. Data for Colombian cases was 104 
accessed via the Instituto Nacional de Salud. Estadísticas SIVIGILA 2017 [Available from: 105 
http://www.ins.gov.co/lineas-de-accion/Subdireccion-106 
Vigilancia/sivigila/Estadsticas%20SIVIGILA/Forms/public.aspx]. [cited 2018 May 05].  107 
Chagas.  Data for Chagas Disease Oral cases in Venezuela originates from English and Spanish 108 
language literature and patient records at the Institute de Medicine Tropical, Caracas. Historical 109 
serological data for Chagas disease in Venezuela and elsewhere was sourced from the literature. 110 
Recent serological data are derived from unpublished records at the Instituto de Medicina 111 
Tropical, Universidad Central de Venezuela. Caracas, Venezuela and the Centro de Medicina 112 
Tropical de Oriente, Universidad de Oriente (UDO) Núcleo Anzoátegui, Barcelona, Venezuela. 113 
Data for vector abundance and infection rates (2014-2016) are also derived from unpublished 114 
records at the at the Instituto de Medicina Tropical, Universidad Central de Venezuela. Caracas, 115 
Venezuela. Data for Colombian cases was accessed via the Instituto Nacional de Salud. 116 
Estadísticas SIVIGILA 2017 [Available from: http://www.ins.gov.co/lineas-de-117 
accion/Subdireccion-Vigilancia/sivigila/Estadsticas%20SIVIGILA/Forms/public.aspx]. [cited 118 
2018 May 05].  119 
Leishmaniasis. Human Cutaneous Leishmaniasis Data from 1990-2016 were sourced from the 120 
National Sanitary Dermatology programme of the Ministery of Health, available from the 121 
Venezuelan Health Observatory (https://www.ovsalud.org/publicaciones/documentos-oficiales/). 122 
Data for Colombian cases was accessed via the Instituto Nacional de Salud. Estadísticas 123 
SIVIGILA 2017 [Available from: http://www.ins.gov.co/lineas-de-accion/Subdireccion-124 
Vigilancia/sivigila/Estadsticas%20SIVIGILA/Forms/public.aspx]. [cited 2018 May 05].  125 
Arboviruses. For dengue, chikungunya and Zika, we used the number of cases reported and 126 
notified for the Surveillance System of the Venezuelan Ministry of Health at national level 127 
during the corresponding epidemics of 2014 and 2015, respectively. Source: Observatorio 128 
Venezolano de la Salud / Documentos Oficiales [Available from: 129 
https://www.ovsalud.org/publicaciones/documentos-oficiales/] [cited 2018 May 05]. Latin 130 
America data were sourced from PAHO Dengue Surveillance Indicators [Available from: 131 
https://www.paho.org/hq/index.php?option=com_topics&view=rdmore&cid=3274&Itemid=407132 
34&lang=es] [cited 2018 May 05]    133 
 134 
 135 
 136 
 137 
 138 
 139 
 140 
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Introduction  141 
 142 
Over the last two decades, Venezuela has transitioned into a deep socioeconomic and political 143 
crisis. Once recognized as a regional leader for public health and vector control policies and 144 
programming, Venezuela’s healthcare has fallen into a state of collapse, creating a severe and 145 
ongoing humanitarian crisis with no end in sight.1,2 146 
 147 
It is a well-known fact that states of political and civil unrest create conditions for the emergence 148 
and spread of infectious diseases3. Venezuela is no exception. With a decaying healthcare 149 
infrastructure, an exodus of trained medical personnel (a full medical professor earns <$10 US 150 
dollars a month), and the decline of all public health programs, the country is witnessing a surge 151 
and expansion of vector-borne diseases.  The UN High Commission for Refugees (UNHCR) 152 
estimates that in the period of 2014-2018, 1.5 million Venezuelans have departed Venezuela for 153 
other countries throughout the Latin American and Caribbean region4. By March 2018, around 154 
40,000 Venezuelan had been estimated to be residing in Brazil, whereas at least 600,000 people 155 
have sought shelter in Colombia5,6. Official data are likely underestimates given the existence of 156 
informal border crossings. Reports of disease spillover to neighbouring countries are increasing 7 157 
 158 
Disease surveillance and reporting has been equally impacted by Venezuela’s healthcare crisis. 159 
Since 1938 the Venezuelan Ministry of Health uninterruptedly issued weekly and monthly 160 
epidemiological reports known as the “Boletín Epidemiológico”. However, in 2007 it suffered a 161 
20 week interruption, regaining its periodicity in November 2014 when it was shut down by the 162 
government 8. More recently in June 2018 the Venezuelan Center for Classification of Diseases -163 
a part of the Division of Epidemiology and Vital Statistics of the Ministry of Health- in charge of 164 
providing PAHO/WHO with updated morbidity and mortality indicators was eliminated by the 165 
government after 63 years of uninterrupted activity.9  166 
  167 
Recently, the return of measles and other vaccine-preventable childhood infections in Venezuela 168 
has been highlighted by the Pan American Health Organization-World Health Organization10. 169 
Herein, we provide a comprehensive overview of the growing epidemics of the major vector-170 
borne diseases - malaria, Chagas disease (CD), leishmaniasis and arboviral infections - in 171 
Venezuela and their ongoing spillover to neighbouring countries based on the limited data 172 
available. We examine the potential impact of such spillover and urge regional healthcare 173 
authorities to declare a public health emergency of hemispheric concern. 174 
 175 
Malaria: a regional menace.  Malaria, one   of   the   most  serious  parasitic  diseases  of the  176 
tropics,   is   caused  by  species of the genus Plasmodium (Apicomplexa:  Plasmodidae)  and   177 
transmitted   among  humans  by  the   bites  of   infected   female  Anopheles   mosquitoes  178 
(Diptera: Culicidae). The World Health Organization (WHO) has established an ambitious plan 179 
for control and elimination of the disease by 2030, and Latin America has made significant 180 
advances to reach that goal, particularly from 2000 to 201511, when symptomatic disease 181 
declined by 62% (from 1,181,095 cases in 2000 to 451,242 in 2015) and malaria-related deaths 182 
by 61.2% (from 410 to 159). Nonetheless, in 2016 a considerable increase in case incidence 183 
(875,000) was reported in the region12. Venezuela accounted for 34.4% of the total reported 184 
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cases in 2016 and has shown dramatic increases since 2000, and particularly since 2012 (Figure 185 
1a).  186 
 187 
During 2016, Plasmodium vivax accounted for 71% of reported cases of malaria in Venezuela, 188 
followed by P.  falciparum (20%) and other Plasmodium infections (~ 9% of mixed and P. 189 
malariae cases)12. Plasmodium vivax cases in Venezuela increased from 62,850 in 2014 to 190 
179,554 in 2016 (a 3-fold increase). By the end of 2017, this number had increased by 37% to 191 
246,85912. Since 2017, numbers of mixed malaria infections have increased, with double (P. 192 
falciparum and P. vivax) and triple (P. vivax, P. falciparum and P. malariae) infections 193 
exhibiting higher than expected rates from the usual occurrence for each species, reflecting a 194 
high level of malaria transmission. Before 2003, malaria in Venezuela followed an endemo-195 
epidemic pattern. Major incidence peaks occurred every 3-6 years in the two main malaria 196 
ecological regions, namely, the southern lowland rainforest and savannahs of Guayana, and the 197 
wetlands of the north-eastern coastal plains13.  From 2003 onwards, the Guayana region, 198 
particularly the Sifontes Municipality, south-eastern Bolívar State (Figure 1b), became the 199 
highest risk area for malaria in the country13,14. In Sifontes, malaria incidence is positively 200 
correlated with an increase in illegal mining activities and forest exploitation. A complex pattern 201 
of limited, albeit persistent hot-spots of Plasmodium transmission is maintained principally by 202 
Anopheles (soon to be Nyssorhynchus) darlingi Root15, An. albitarsis Lynch s.l. and An. 203 
nuneztovari Gabaldon s.l.16,17, which show high natural parasite infection rates (4.0%, 5.4% and 204 
0.5%, respectively).  205 
 206 
It has been observed that clearing forests for mining activities creates favourable conditions for 207 
An. darlingi and An. albitarsis breeding18. An increase in illegal mining activities is likely to be 208 
strongly linked to the economic crisis. Highly mobile, often immunologically naïve, human 209 
populations migrate from different regions of the country to mining areas in search of economic 210 
opportunities. Once they arrive, they live outdoors, constantly exposed to mosquito bites. Many 211 
internal migrants return to past-endemic malaria regions where viable Anopheles vector 212 
populations exist, reintroducing malaria to areas where this infection had been previously 213 
eliminated. In addition, financial constraints generated by the current crisis have severely limited 214 
the procurement of malaria commodities (e.g., insecticides, drugs, diagnostic supplies, mosquito 215 
nets, etc.), and hampered epidemiological surveillance, reporting activities, vector-control and 216 
disease-treatment efforts2,19.  Internal economic migration of miners and their families combined 217 
with a lack of provision and implementation of curative and prevention services previously 218 
provided by the state has created ideal conditions for malaria epidemics and increases in 219 
morbidity and mortality. Since 2014, local malaria transmission has reemerged in new areas of 220 
the country producing a significant change in the epidemiological landscape of this disease. 221 
Endemic malaria transmission is now beginning to propagate across the whole country, including 222 
urban and peri-urban foci, combined with an increase in hot-spots which persist in the Guayana 223 
region (Figure 1b). However, the numbers presented in Figure 1 are likely to represent an 224 
underestimate of the current situation as P. vivax case relapses are often not reported. Such cases 225 
are on the rise due to primaquine and chloroquine non-adherence as a result of antimalarial drugs 226 
stock-outs. Furthermore, recent findings have revealed that there are four asymptomatic carriers 227 
per symptomatic case with similar findings in Colombia and Brazil.20 228 
 229 
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The rapidly increasing malaria burden in Venezuela and the exodus of its citizens continues to 230 
impact neighbouring countries, particularly Brazil and Colombia. According to the Brazilian 231 
Ministry of Health, a total of 47,968 malaria cases were reported in the neighbouring Roraima 232 
State from 2014 to 2017 (Figure 2), of which around 20% (9,399) were imported from 233 
Venezuela. Numbers of such cases increased from 1538 (2014) to 3129 (2017). Figures from 234 
2016 represent up to 45% and 86% of the reported malaria cases in the border municipalities of 235 
Pacaraima and Boa Vista, respectively (Figure 2). The continued upsurge of malaria in 236 
Venezuela could soon become uncontrollable; jeopardizing the hard-won gains of the malaria 237 
control programme in Brazil and other countries in the region. With 406,000 cases in 2017, 238 
Venezuela may now exhibit the largest malaria increase reported worldwide7, threatening the 239 
successful implementation of the Global Malaria Action plan.21 240 
 241 
Chagas Disease: persistent endemism and resurgence. Chagas disease (CD) is caused by the 242 
kinetoplastid parasite Trypanosoma cruzi that currently infects approximately six million people 243 
world-wide. CD is a complex zoonosis involving multiple mammal and blood sucking triatomine 244 
bug species 22. Human infection with T. cruzi leads in approximately 40% of cases to severe and 245 
irreversible cardiac and intestinal pathology23.CD has remained endemic in Venezuela since its 246 
first description in 1919. In the 1960s and 1970s seroprevalence was 43.9% overall, and 20.4% 247 
in young children (aged <10 years, a key indicator of active transmission)24,25. Efforts to interrupt 248 
CD transmission, alongside widespread insecticide use against malaria vectors, succeeded in 249 
reducing sero-prevalance to 9.2% and the geographical extent of transmission risk by 52% 26. 250 
Seroprevalence among young children (0-10) was reduced to 0.5% between 1990-9826. 251 
Regrettably, the 1990s saw the national CD control program reduced and decentralised26. 252 
Moreover, CD control in Venezuela is hindered by the ecology of the principal vector, Rhodnius 253 
prolixus, which frequently invades and colonises rural houses from wild foci after insecticide 254 
spraying. Thus, even prior to the current economic crisis, Venezuela was at risk of resurgent CD. 255 
Since 2012, the surveillance and control of CD transmission in Venezuela have been abandoned. 256 
By piecing together unpublished data from several sources we can report herein multiple 257 
hotspots of new and active disease transmission. 258 
 259 
In the Andes and Western Venezuela, CD is present throughout different states regardless of the 260 
geographical or climatic landscape. Seroprevalences obtained from three endemic communities 261 
(2014-2016) in Portuguesa States show considerable active transmission (12.5%, <10 years old, 262 
Table S1, Figure 3a). Also, house infestation indices were estimated to be as high as 24.8% in 263 
some hotspots at the time the CD control-program was dismantled27. Seroprevalences observed 264 
in Lara State in 2011 also suggest some active transmission (0.57%, <10 years old, Table S1, 265 
Figure 3a)27-29. Recent estimates for this and other western States are not available, however, 266 
CD may well be resurgent as no surveillance or preventative measures are in place. At the time 267 
of writing an outbreak of acute Chagas in Táchira State reported in the Colombian media had 268 
infected 40 people and claimed eight lives30. Eleven cases of ‘spillover’ acute disease in total 269 
were confirmed in Venezuelan nationals by the Colombian authorities in the last six months. In 270 
contrast to western Venezuela, in the 2000s, studies suggested that elimination of vectorial 271 
transmission of CD in eastern Venezuela was possible26. However, recent data reveals that active 272 
transmission is now present in Nueva Esparta State (2.5%, <10 years old, 2016, Table S2, 273 
Figure 3a), Anzoátegui State (8%, 11-20 years old, 2014, Table S2, Figure 3a) and Sucre State 274 
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(2%, 11-20 years old, 2012, Table S2). In Nueva Esparta, most seropositive subjects were among 275 
the young and the elderly – possibly reflecting the success of the former control program and 276 
current resurgence of the disease (Table S2, Figure 3a). Overall sero-prevalence among children 277 
from the data we report (4.3%, <10 years old, Table S3) indicates resurgent infection and 278 
resembles rate estimates from the 1970s26. However, our sample sizes are at least one order of 279 
magnitude lower than historical studies, although the serological approaches were similar 280 
(ELISA, IHA and FC). Nationally, seroprevalences over all age groups (15.7%, Table S3) 281 
exceed those in endemic provinces in Colombia (Boyaca, 2·2% 2007-09; Santander 0.2%, 2013-282 
1431) as well as Ecuador (3.5%, Manabi, Loja, Guayas (2001-2003)32 by a substantial margin. It 283 
is not clear whether blood banks are still being screened for CD in Venezuela, however in the 284 
current crisis it seems unlikely.  285 
 286 
Oral CD transmission has also become an issue of great concern. Between 2007 and 2018 sixteen 287 
outbreaks of oral CD have been recorded nation-wide and ten have been managed through the 288 
outpatient clinic of the Institute of Tropical Medicine, Caracas ((Table S4, Figure 3)33,34 The 289 
updated data are shown in Table S4 with 321 cases and 23 deaths in ten years. Such outbreaks 290 
have frequently been associated to consumption of artisan fruit juices contaminated with infected 291 
triatomines (especially the vector species Panstrongylus geniculatus) or their feces, exhibiting a 292 
severe clinical course and high mortality35.  Urbanization and deforestation of wooded areas 293 
where the triatomines are present may also be contributing to this situation2. Half of these 294 
outbreaks have occurred in and around Caracas, though reports from other geographic regions 295 
are arising with many undiagnosed cases remaining unreported due to the non-specific signs and 296 
symptoms as well as physicians’ unfamiliarity with the acute phase of the disease. Current severe 297 
drug shortages have forced patients to cross the borders in search of treatment and/or medical 298 
care in neighbouring countries. Moreover, the monitoring of these patients is essential because 299 
treatment with the only existing drugs (Benznidazole and Nifurtimox) is not totally effective, a 300 
situation exacerbated by the current low availability of these agents in Venezuela, as well as the 301 
medical personnel to administer them.36  302 
 303 
Linked to several oral CD outbreaks in and around Caracas are increasing reports of peri-urban 304 
transmission of T. cruzi in Venezuela. This phenomenon was first reported in 2005 where 76.1% 305 
of the disease vector Panstrongylus geniculatus recovered from the Capital District and Miranda 306 
and Vargas states were naturally infected with T. cruzi and that 60.2% of their gut contents gave 307 
a positive reaction to human antiserum37. Ongoing collections between 2007-2016 has continued 308 
to reveal a preponderance of P. geniculatus (98.96%), as well as Triatoma nigromaculata 309 
(0.58%), Triatoma maculata (0.37%), Rhodnius prolixus (0.07%) and Panstrongylus 310 
rufutuberculatus (0.02%) (Figure 3b)38. Vector infection rates with T. cruzi over this period have 311 
been consistently high (75.7%). Intradomiciliary triatomine nymphs also present in 16 of the 32 312 
parishes (3.42% of vectors captured) suggest active colonisation of houses by these insects. 313 
Preliminary molecular analysis of blood meals identify humans as by far the most common blood 314 
feeding source among insects collected 2007-2016.  Furthermore, molecular epidemiological 315 
analyses clearly identify parasites from these peri-urban transmission cycles as the source of 316 
local oral outbreaks39.  It is not known to what extent vectors are also transmitting parasites 317 
directly to human populations in the metropolitan district (i.e. not orally via contaminated food). 318 
9 
 
However, given high rates of feeding on humans, as well high infection levels, vectoral 319 
transmission remains a possibility despite the supposed low vectoral capacity of P. geniculatus38. 320 
 321 
Leishmaniasis: an early wake-up call. Leishmaniasis refers to a spectrum of diseases caused by 322 
a several trypanosomatid species belonging to the genus Leishmania (old and new world) and 323 
subgenus Viania (new world). Leishmania is transmitted via the bite of infected phlebotomine 324 
sandflies. In Venezuela, leishmaniasis is widely distributed, with most endemic zones located 325 
throughout the valleys of the coastal mountain range, the Yaracuy River basin (West), some 326 
areas of the central plains (Llanos) and the Andean mountain forests. Isolated endemic foci south 327 
of the Orinoco River in the Amazon basin have also been reported, but still remain to be fully 328 
characterized.40 329 
 330 
As per data of the National Sanitary Dermatology programme of the Minister of Health, 61,576 331 
cases of cutaneous leishmaniasis (CL) occurred between the period 1990-2016, with 332 
approximately 75% of the cases occurring in the States of Táchira, Mérida, Trujillo, Lara, 333 
Miranda and Sucre (Figure 4a&b). In recent years, leishmaniasis-endemic regions in Venezuela 334 
have expanded significantly, linked to ever-increasing trends towards urbanization, deforestation, 335 
environmental changes and the emergence of focal peri-urban transmission cycles as reported in 336 
several cities in the States of Lara and Trujillo.40 There is nothing in the available data to suggest 337 
that the frequency of different clinical manifestations of CL (muco-cutaneous, disseminated and 338 
diffuse) – has been impacted by the crisis.   339 
 340 
Visceral Leishmaniasis is prevalent in three endemic foci across Venezuela. The central foci that 341 
embraces the states of Guarico-Carabobo-Cojedes and Aragua, the western foci embracing 342 
Portuguesa, Lara and Trujillo; and the eastern foci which includes Sucre, Anzoategui and the 343 
insular state of Nueva Esparta 40. Between 1961 and 1991 reports revealed the occurrence of 675 344 
cases nationwide, however this may be an underestimate of the real situation. More recent sero-345 
epidemiological surveys indicate that during 2004-2012, there was a prevalence of 14.8% 346 
amongst 15,822 dogs evaluated, with Lara and Guarico demonstrating the highest seroprevalence 347 
with most dogs (81%) showing no clinical signs41 . It is possible that migratory trends may be 348 
contributing to the spread of the disease from its traditional endemic rural niches into peri-urban 349 
ecotopes where the presence of vectors (Lutzomyia longipalpis and Lutzomyia evansi) may aid 350 
the installment of new authoctonous foci40.  351 
 352 
The risk of Leishmania transmission has historically been influenced by migrations, refugee 353 
crises, wars and states of civil unrest, including cross-border movement of cases and notably in 354 
recent conflicts in Syria and Yemen.42-44,34,35,36,37,38.39. Cross-border dispersal of Leishmania 355 
species from Venezuela is already occurring and several cases of VL and CL have been detected 356 
in Venezuelan migrants to Colombia in the last six months45.  357 
 358 
Arboviruses: an expanding threat. Viruses that are transmitted by arthropod vectors 359 
(arboviruses) have been expanding either steadily or in explosive (re)-emergent epidemics in 360 
recent years, posing a growing threat to global public health46,47. In the last four years, the two 361 
major epidemics that swept the American continent were caused by the chikungunya and Zika 362 
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arboviruses48. Concomitantly, dengue, another arboviral disease endemic in the Latin American 363 
region, is increasing its spread to previously unaffected areas. All three arboviruses are 364 
transmitted by the same mosquito, Aedes (Stegomya) aegypti (L.), with a potential role for the 365 
invasive species Ae. (Stegomya) albopictus (Skuse) as well. 366 
 367 
A member of the Flaviviridae family, dengue virus has become a major public health problem in 368 
Venezuela. Four dengue virus serotypes (DENV-1 to DENV-4) co-circulate in the country, each 369 
of them capable of causing the entire range of dengue-related disease symptoms. Infected 370 
individuals can be asymptomatic or present with clinical manifestations varying from mild 371 
febrile illness, to severe disease and death49. Venezuela is witnessing an upswing in incidence, 372 
frequency and magnitude of dengue epidemics against a background of perennial endemic 373 
transmission. Dengue incidence has leaped from an average of 39.5 cases per 100,000 population 374 
in the early 1990’s to a 9-fold higher mean incidence of 368 cases per 100,000 population 375 
between 2010 and 2016 (Figure 5a). Within the country, the temporal increase in dengue cases 376 
mirrors the national dengue incidence with regions of higher population density (central regions) 377 
and those bordering Colombia and Brazil (border regions) exhibiting a higher incidence (Figure 378 
5b). Worryingly, a total of six increasingly large epidemics were recorded nationally between 379 
2007-2016 compared with four epidemics in the previous 16 years50. The largest occurred in 380 
2010, when approximately 125,000 cases including 10,300 (8.6%) with severe manifestations 381 
were registered. During that year, Venezuela ranked third in the number of reported dengue cases 382 
in the American continent and second in the number of severe cases51. 383 
 384 
The combination of poverty-related socioeconomic factors, such as increasingly crowded living 385 
conditions, growing population density, precarious homes and long-lasting deficits in public 386 
services including frequent and prolonged interruptions in water supply and electricity have been 387 
linked with a greater risk of acquiring dengue infection in Venezuela52–55. These inadequacies 388 
have obliged residents to store water within households maintaining suitable breeding conditions 389 
for Ae. aegypti vectors during the dry season and throughout the year, driving perennial dengue 390 
transmission. Additionally, the failure of vector control programs has resulted in the proportion 391 
of houses infested with Ae. aegypti to surpass the WHO transmission threshold56. Such 392 
conditions set the stage for subsequent arboviral epidemics. 393 
 394 
Venezuela was not spared from the havoc that the epidemics of chikungunya (in 2014) and Zika 395 
(a year later).. The impact of these epidemics was amplified by the lack of timely official 396 
information, lack of preparedness, and the worsening economic and health crisis resulting in 397 
acute shortages of diagnostics medicines and medical supplies, and an overburdened health 398 
system. Both epidemics rapidly spread through densely inhabited regions where dengue 399 
transmission is high. Although nationally, the attack rate of chikungunya was estimated to be 400 
between 6.9% and 13.8%57, the observed attack rate in populated urban areas reached 40-50%, 401 
comparable or higher than that reported in other countries58,59. The total number of chikungunya 402 
cases in Venezuela reported to PAHO in 2014 (by epidemiological week 51) was 34,945, with an 403 
incidence of 121.5 per 100,000 population60. Given the paucity of official information since 404 
October 2014, estimates created based on excess fever cases not explained by another cause 405 
suggest that there were more than 2 million cases of chikungunya, resulting in an incidence of 406 
6,975 cases per 100,000 population, more than 12 times the rate reported officially by the 407 
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Venezuelan Ministry of Health57. Moreover, an important, yet unknown, number of atypical and 408 
severe/fatal cases of chikungunya61 occurred but were not reported by health personnel because 409 
of fear of governmental reprisal.1,62 410 
 411 
In January 2016, the Zika epidemic struck Venezuela concomitantly with a rise in dengue 412 
transmission. The Zika outbreak evolved in a similar manner as chikungunya, rapidly affecting a 413 
high proportion of the population. Lack of preparedness and of official communication once 414 
again sparked alarm. The incidence of symptomatic cases during the peak of the epidemic was 415 
estimated at 2,057 cases per 100,000 population63. Current estimates of serologically (IgG) Zika 416 
positivity in pregnant women have reached roughly 80%. As in other countries, an increase in 417 
the number of cases of Guillain-Barré syndrome (GBS) was observed during the epidemic. 418 
However, Venezuela experienced a rise of 877% (9.8 times higher) in GBS incidence compared 419 
to the pre-Zika baseline incidence, one of the highest (if not the highest) reported in the 420 
Americas64. The number of GBS cases surged from a mean of 214 annual cases reported before 421 
Zika to more than 700 confirmed cases since the epidemic started63. Cases of microcephaly and 422 
other congenital disorders related to Zika infections in pregnancy in Venezuela have been 423 
reported, but the incidence remains to be determined by ongoing studies. 424 
 425 
Beyond chikungunya, Zika and dengue viruses, other circulating arboviruses with epidemic 426 
potential exist in Venezuela. Mayaro has caused recent outbreak65,66 and is often confused with 427 
chikungunya. Oropouche (Madre de Dios virus, outbreak in Perú, 2016) was recently detected in 428 
the Llanos of Venezuela, outside its typical distribution zone67. The occurrence of cryptic 429 
transmission cycles and cases due to epizootic strains of Venezuelan Equine Encephalitis and 430 
Madariaga virus (South American Eastern Equine Encephalitis)68 when immunization programs 431 
have been halted pose a further threat. No facilities exist for rapid laboratory diagnosis for either 432 
virus in Venezuela.69 The most common and effective VEE vaccine, TC-83, can longer be 433 
bought or produced in the Venezuela. The Agricultural Research Institute (INIA), with limited 434 
production capacity, has no financial support and production is paralyzed. Although there are no 435 
reliable official records of equine inventories, wild donkeys without owners and without sanitary 436 
control, and persistent circulation of epizootic VEE strains in inter-epizootic periods in different 437 
sites of the plains and the Catatumbo region, increases the threat of latent outbreaks and their 438 
potential international dispersal.70 439 
 440 
The whole of Latin America is experiencing increased risks and outbreaks associated with 441 
arboviruses. Although there is currently no evidence to suggest that the prevalence of certain 442 
arboviruses like dengue is higher in Venezuela than in other countries (Figure 5a), the lack of 443 
public health infrastructure available for diagnosis and treatment is now a disproportionate 444 
problem in Venezuela compared with other countries in the region. Furthermore, given the 445 
current situation, widespread underreporting of cases by comparison to other countries in the 446 
region is also possible. The lower incidence and lack of parallel increase after 2013 of dengue in 447 
Venezuela compared to Colombia and Brazil, for example (Figure 5a), strongly suggest chronic 448 
underreporting. In light of the precarious possibilities for cure in Venezuela combined with the 449 
high level of population displacement, emigrating infected individuals could be unwittingly 450 
causing a spillover of arboviral diseases to neighbouring countries, a process that has not yet 451 
been quantified. The first major outbreak of dengue on the island of Madeira in 2012-2013 is an 452 
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example of the disease export potential of Venezuela, as this outbreak was directly linked with a 453 
DENV-1 serotype from Venezuela.71 454 
 455 
A call for action.  456 
For many decades, Venezuela was a leader in vector control and public health policies in Latin 457 
America, even more so after becoming the first WHO-certified country to eliminate malaria in 458 
most of its territory in 196172. The interruption of malaria transmission was achieved through 459 
systematic and integrative infection and vector control, case management, preventive diagnosis, 460 
patient treatment, mass drug administration, community participation through volunteer 461 
community health workers and sanitary engineering such as housing improvement and water 462 
management. This integrative approach differs little from current ‘best-practice’ prevention, 463 
control and elimination of malaria. Indeed, the success Venezuelan public health intervention 464 
helped to stimulate interest in global malaria elimination during the 1960s72.  465 
Paradoxically, the onchocerciasis (a vector-borne helminth infection) elimination program in 466 
Venezuela has continued to work reasonably well. The program’s success is underpinned by the 467 
commitment and resolve of its Venezuelan local health workers and indigenous health agents 468 
and under the regional support of the Onchocerciasis Elimination Program for the Americas 469 
(OEPA)2. As a result of long-term Mass Drug Administration (MDA) with ivermectin (labeled as 470 
Mectizan®; Merck & Co., Inc., Kenilworth, NJ, USA) on a biannual (and four times per year) 471 
basis starting in 2000, interruption of onchocerciasis has been achieved among the northern foci 472 
located in the coastal mountain area73, and parasite transmission now remains in just 25% of the 473 
Venezuelan Yanomami southern Amazonian region74. This regional initiative has proven that the 474 
consensus of ministries of health, the endemic communities, non-governmental organizations, 475 
and public-private stakeholders, including the WHO, is required to develop and implement 476 
effective public health programs2,72. 477 
 478 
Venezuelans have endured a decade of political, social, and economic upheaval that has left a 479 
country in crisis. In addition to a return of measles and other vaccine-preventable infectious 480 
diseases, conditions are favouring the unprecedented emergence and transmission of vector 481 
borne diseases. Underpinning the current epidemic(s) is a lack of surveillance, a lack of 482 
education and awareness, and a lack of capacity for effective intervention. Successful control of 483 
the emerging crisis requires regional coordination and, as we demonstrate in this report, cross-484 
border spillover is already ongoing, and expected to increase. 485 
 486 
Fortunately, many solutions are within reach, even with limited resources. A good example is the 487 
recent successful bi-national strategy for the elimination of malaria on the Peru-Ecuador border. 488 
Collaboration at the operational level that included strengthening surveillance, community 489 
personnel trained to collect blood smears from febrile persons within their border communities, 490 
prompt effective diagnosis, case definition (indigenous, imported, introduced, induced, cryptic), 491 
and treatment75. Where state infrastructure fails, however, surveillance can be achieved via the 492 
mobilisation of citizen scientists and informal networks of healthcare professionals. 493 
Technological advances in low-cost sample preservation, passive sampling and in situ 494 
diagnostics can also contribute. Education to raise awareness among communities at risk from 495 
disease can be achieved via social media, initiatives at schools and information campaigns at 496 
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public centers. Surveillance data are power and must be used as an advocacy tool to raise 497 
awareness among Venezuelan and regional authorities, and ultimately better allow them to 498 
recognise the growing crisis, cooperate, and accept international medical interventions. Relevant 499 
international health authorities such as the WHO Global Outbreak Alert and Response Network 500 
(GOARN) must also move towards maintaining accurate disease surveillance and response 501 
systems in the region along with collaboration with other strategic partners in order to provide 502 
timely humanitarian assistance throughout this ongoing crisis. The wider scientific community 503 
must support this process by engaging with their Venezuelan and regional colleagues, 504 
contributing to a robust, non-partisan evidence base for such interventions. Ultimately national 505 
and international political commitments are essential to stop a health crisis that threatens the 506 
whole region.   507 
 508 
It must be recognized that the emergence or re-emergence of vector-borne neglected diseases is 509 
now extending beyond the borders of Venezuela.  We have already seen how these diseases have 510 
extended into neighbouring Brazil and Colombia, but with increasing air travel and human 511 
migrations, the entire Latin American and Caribbean region is at heightened risk for disease re-512 
emergence, as well as some US cities hosting the Venezuelan diaspora, including Miami and 513 
Houston. Accordingly, we call on the members of the Organization of American States (OAS) 514 
and other international political bodies to become better and more effectively engaged in 515 
strengthening Venezuela’s now depleted health system by applying more pressure to the 516 
government to accept humanitarian assistance offered by the international communuty2. Without 517 
such international interventions there is a real possibility that public health gains achieved over 518 
the last 18 years through Millennium Development Goal 6 (“to combat AIDS, malaria, and other 519 
diseases”) and the new Sustainable Development Goals could be soon reversed.   520 
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Figure Legends: 521 
 522 
Figure 1. (a) Number of confirmed malaria cases (line) and Annual parasite incidence (API: 523 
No. of confirmed malaria cases/1,000 inhabitants, bars) in Venezuela from 2000 to 2016 (inset 524 
left: map of Venezuela (red) in South America, inset right: case comparison of annual incidence 525 
(Y-axis) for Colombia, Brazil & Venezuela). Temporal pattern of incidence indicates an 526 
exponential increasing trend (R2= 0.78, P = 1.07x10-5, N=18) in Venezuela. (b) API for each 527 
municipality in Venezuela during 2016  528 
 529 
Figure 2. Map of malaria cases reported in Eastern Venezuela and neighbouring Brazilian 530 
Roraima state in Brazil (a) 2014, (b) 2015, (c) 2016. For Roraima state, maps indicate 531 
autochthonous (A) and imported (I) confirmed malaria cases coming from Venezuela. 532 
 533 
Figure 3 (a) Update on the distribution of Chagas disease human seroprevalance data and 534 
sites of oral outbreaks in Venezuela. States for which data are available are coloured by 535 
percent overall seroprevalence (left to right: Nueva Esparta, Sucre, Anzoátegui, Guárico and 536 
Portuguesa). Pie charts indicate infection among different age classes. Blue diamonds indicate 537 
sites of reported oral outbreaks. (b) Distribution of peri-urban vectors and Trypanosoma cruzi 538 
infection status around Caracas. Upper map and legend detail details count data for 539 
triatomines brought to clinic at the Insitito de Medicine Tropical 2007-2016, by municipality. 540 
Lower map and legend show T. cruzi infection prevalence (%) in the same vectors.  541 
 542 
Figure 4. (a) Number of confirmed cases (line) and Annual cutaneous leishmaniasis 543 
incidence per 100,00 inhabitants (bars) in Venezuela from 2006 to 2016. (b) Incidence 544 
heatmap of cutaneous leishmaniasis by State per 100,000 inhabitants for the 2006-2016 545 
period (increasing from blue to red).  546 
 547 
Figure 5. (a) Annual dengue incidence (per 100,000 inhabitants) for the 1991-2016 period. 548 
Black vertical arrows indicate dengue epidemic years (inset: comparison of incidence data (Y-549 
axis) for Colombia, Brazil & Venezuela). Dotted black line indicates an increasing linear trend 550 
(R2= 0.27, t=2.99, P = 0.006, N=26). (b) Heatmap showing the annual dengue incidence 551 
(increasing from blue to red) per State in Venezuela from 1991 to 2016.  552 
 553 
 554 
 555 
  556 
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